Farms.com Home   News

Newly Funded: University of Minnesota Researchers Secure $500K USDA Grant to Study Novel Pig Influenzas

A team of researchers at the University of Minnesota has secured $500,000 to study how new influenza virus strains emerge, persist, and spread in pig populations--and what age, well-being, farm-production type, and epidemiological factors might help predict whether a new virus strain emerges.

Though most pigs recover from influenza, the virus affects pork producers financially because infected pigs take longer to gain weight--meaning more time on the farm prior to market. The most common cause of new infectious strains in both pigs and people is something called viral gene reassortment, which occurs when two different influenza viruses infect the same cell and then swap gene segments.

Click here to see more...

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.